Article
Rethinking pheochromocytomas and paragangliomas from a genomic perspective.
Oncogene - 3 Mar 2016
Castro-Vega L J, Lepoutre-Lussey C, Gimenez-Roqueplo A-P, Favier J
Abstract excerpt
Pheochromocytomas (PCC) and paragangliomas (PGL) are rare neuroendocrine tumors of neural crest origin. These tumors are caused by germline or somatic mutations in known susceptibility genes in up to 70% of cases. Over the past few years, the emergence of high-throughput technologies has enabled the unprecedented characterization of genomic alterations in PCC/PGL, and has improved our understanding of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
